Welcome to the international HTA database

Showing [24040 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2017	HAYES, Inc.	Fecal calprotectin assay for monitoring disease activity in Crohn disease
2017	Basque Office for Health Technology Assessment (OSTEBA)	[Updating of the shared work system for systematic reviews of the evidence and critical appraisal (FLC 3.0 Platform)]
2017	NIHR Health Technology Assessment programme	Real-time modelling of a pandemic influenza outbreak
2017	Health Quality Ontario (HQO)	Patient safety learning systems: a systematic review and qualitative synthesis
2017	HAYES, Inc.	Local injection therapy for cervicogenic headache and occipital neuralgia
2017	Basque Office for Health Technology Assessment (OSTEBA)	[System for percutaneous replacement of mitral valve (MitraClip). Monitoring Study Protocol (1st part)]
2017	Health Quality Ontario (HQO)	Pharmacogenomic testing for psychotropic medication selection: a systematic review of the Assurex GeneSight Psychotropic test
2017	HAYES, Inc.	Positron emission tomography-computed tomography (PET-CT) for detection of primary site in neuroendocrine tumors of unknown origin
2017	Basque Office for Health Technology Assessment (OSTEBA)	[System for percutaneous replacement of mitral valve using a Clip. Monitoring study (part 2)]
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dual antiplatelet therapy following percutaneous coronary intervention: a review of the clinical impact of treatment duration
2017	HAYES, Inc.	The clinical utility of lumbar discography for assessing low back pain: impact on patient management and health outcomes
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Proton beam therapy for the treatment of cancer in children and adults: a health technology assessment
2017	NIHR Health Technology Assessment programme	A randomised controlled trial to compare the safety, effectiveness and cost effectiveness of doxycycline (200 mg/day) with oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial
2017	NIHR Health Technology Assessment programme	A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
2017	HAYES, Inc.	Transcatheter closure of prosthetic aortic or mitral paravalvular leaks
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	New drugs for type 2 diabetes: second-line therapy - science report
2017	Agency for Healthcare Research and Quality (AHRQ)	Glasgow Coma Scale for field triage of trauma: a systematic review
2017	HAYES, Inc.	Wireless capsule systems for diagnosis of gastroparesis and monitoring of gastrointestinal motility
2017	Agency for Healthcare Research and Quality (AHRQ)	Tonsillectomy for obstructive sleep-disordered breathing or recurrent throat infection in children
2017	NIHR Health Services and Delivery Research programme	Cross-national mixed-methods comparative case study of recovery-focused mental health care planning and co-ordination in acute inpatient mental health settings (COCAPP-A)
2017	Agency for Healthcare Research and Quality (AHRQ)	First- and second-generation antipsychotics in children and young adults: systematic review update
2017	NIHR Health Services and Delivery Research programme	Investigating the organisational factors associated with variation in clinical productivity in community pharmacies: a mixed-methods study
2017	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dialysis modalities for the treatment of end-stage kidney disease: a health technology assessment
2017	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Care needs assessment tools]
2017	Agency for Healthcare Research and Quality (AHRQ)	Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer's-type dementia
2017	NIHR Health Services and Delivery Research programme	Quality and reporting standards, resources, training materials and information for realist evaluation: the RAMESES II project
2017	Agency for Healthcare Research and Quality (AHRQ)	Preventing complications and treating symptoms of diabetic peripheral neuropathy
2017	NIHR Health Services and Delivery Research programme	Optimal NHS service delivery to care homes: a realist evaluation of the features and mechanisms that support effective working for the continuing care of older people in residential settings
2017	NIHR Health Technology Assessment programme	Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction)
2017	Agency for Healthcare Research and Quality (AHRQ)	Assessment tools for palliative care
2017	NIHR Health Services and Delivery Research programme	Variations in mortality across the week following emergency admission to hospital: linked retrospective observational analyses of hospital episode data in England, 2004/5 to 2013/14
2017	Agency for Healthcare Research and Quality (AHRQ)	Treatment of osteoarthritis of the knee: an update review
2017	NIHR Public Health Research (PHR) programme	Assessing the impact and cost-effectiveness of needle/syringe provision and opiate substitution therapy on hepatitis C transmission among people who inject drugs in the United Kingdom: analysis of pooled datasets and economic modelling
2017	NIHR Health Technology Assessment programme	Timing of surgical intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip 'Op)
2017	Agency for Healthcare Research and Quality (AHRQ)	Tympanostomy tubes in children with otitis media
2017	NIHR Public Health Research (PHR) programme	Adapting the ASSIST model of informal peer-led intervention delivery to the Talk to FRANK drug prevention programme in UK secondary schools (ASSIST + FRANK): intervention development, refinement and a pilot cluster randomised controlled trial
2017	NIHR Public Health Research (PHR) programme	Results of the First Steps study: a randomised controlled trial and economic evaluation of the Group Family Nurse Partnership (gFNP) programme compared with usual care in improving outcomes for high-risk mothers and their children and preventing abuse
2017	NIHR Health Technology Assessment programme	CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017	NIHR Public Health Research (PHR) programme	Could scale-up of parenting programmes improve child disruptive behaviour and reduce social inequalities? Using individual participant data meta-analysis to establish for whom programmes are effective and cost-effective
2017	National Institute for Health and Care Excellence (NICE)	Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib. NICE technology appraisal guidance 427
2017	NIHR Health Technology Assessment programme	Accessibility and implementation in the UK NHS services of an effective depression relapse prevention programme: learning from mindfulness-based cognitive therapy through a mixed-methods study
2017	National Institute for Health and Care Excellence (NICE)	Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy. NICE technology appraisal guidance 428
2017	National Institute for Health and Care Excellence (NICE)	Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation. NICE technology appraisal guidance 429
2017	Belgian Health Care Knowledge Centre (KCE)	Bevacizumab in the treatment of ovarian cancer
2017	National Institute for Health and Care Excellence (NICE)	Sofosbuvir-velpatasvir for treating chronic hepatitis C. NICE technology appraisal guidance 430
2017	National Institute for Health and Care Excellence (NICE)	Everolimus for advanced renal cell carcinoma after previous treatment. NICE technology appraisal guidance 432
2017	National Institute for Health and Care Excellence (NICE)	Apremilast for treating active psoriatic arthritis. NICE technology appraisal guidance 433
2016	NIHR Health Technology Assessment programme	Psychoeducation with problem-solving (PEPS) therapy for adults with personality disorder: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manualised intervention to improve social functioning
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Andexanet alfa for acute major bleeding episodes requiring reversal of anticoagulation, including reversal of factor Xa inhibition – first line
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Impact evaluation of optimal use guidelines implementation for self-monitoring of blood glucose by adult patients with type 2 diabetes and not using insulin]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Blinatumomab - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Intrathecal idursulfase (Elaprase) for Hunter syndrome (mucopolysaccharidosis type II)
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides for the pharmacological treatment of STBBIs]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Carfilzomib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nusinersen for paediatric-onset spinal muscular atrophy – first line
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Extracorporeal photopheresis: main indications and implementation parameters]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for refractory myasthenia gravis
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal long-term use of proton pump inhibitors]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Aflibercept (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Voke 0.45mg inhaler for smoking cessation – first line
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Magnetic resonance spectroscopy and magnetic resonance imaging with tractography for psychiatric disorders
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rectal cancer investigation, treatment and follow-up algorithm]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Regorafenib - Addendum to Commission A15-43]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Crisaborole for adults, adolescents and children with atopic dermatitis
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Prostate bipolar transurethral resection for the treatment of benign prostatic hyperplasia
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Colon cancer investigation, treatment and follow-up algorithm (update)]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Netarsudil for open-angle glaucoma or ocular hypertension
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Eculizumab in nocturnal paroxysmal hemoglobinuria and atypical hemolytic-uremic syndrome
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Feasibility and appropriateness of implementing satellite radiotherapy centres equipped with a single linear accelerator]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Lumacaftor/ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016	NIHR Health Technology Assessment programme	The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Mitomycin ophthalmic (Mitosol) for glaucoma surgery
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Augmentative and alternative communication device with eye tracking (TOBII) in language and motor speech disorders
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Evidence brief on the measures related to the reimbursement of blood glucose test strips]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "rheumatoid arthritis"]
2016	NIHR Health Services and Delivery Research programme	Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventions
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Enzyme replacement therapy in Gaucher Disease
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effect of palivizumab prophylaxis in reducing the complications associated with the respiratory syncytial virus in infants and young children]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Secukinumab (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	NIHR Health Services and Delivery Research programme	Integrated care to address the physical health needs of people with severe mental illness: a rapid review
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Sacubitril in combination with valsartan for chronic heart failure
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Cobimetinib - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	An enhanced recovery after surgery program for hip and knee arthroplasty
2016	NIHR Health Technology Assessment programme	Modelling disease progression in relapsing remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort
2016	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Endoscopic radiofrequency ablation in gastroesophageal reflux disease
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Efmoroctocog alfa - Benefit assessment according to § 35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	LINX reflux management system
2016	Agency for Healthcare Research and Quality (AHRQ)	Diabetes medications for adults with type 2 diabetes: an update
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Ultrasound of peripheral nerves
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Rilpivirine (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cryotherapy, radioablation and irreversible electroporation for prostate cancer
2016	Agency for Healthcare Research and Quality (AHRQ)	Imaging for the pretreatment staging of small cell lung cancer
2016	Institute for Clinical Effectiveness and Health Policy (IECS)	Positron emission tomography/magnetic resonance imaging (PET/MRI) in cancer
2016	Institut national d'excellence en sante et en services sociaux (INESSS)	[Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]